Observational studyThorax2023
Estimating the attributable fraction of mortality from acute respiratory distress syndrome to inform enrichment in future randomised clinical trials.
Observational study in Thorax, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 19 citations in OpenAlex.
- Epidemiology of the acute respiratory distress syndrome and the prognostic validity of SpOCritical care (London, England) · 2026Article
- Imaging and pulmonary function techniques in ARDS diagnosis and management: current insights and challenges.Critical care (London, England) · 2025Review
- Predictive validity of the sequential organ failure assessment score for mortality in patients with acute respiratory distress syndrome in Vietnam.Scientific reports · 2025Observational
- Expert perspectives on ECCOAnnals of intensive care · 2024Article
- Incidence of acute kidney injury and attributive mortality in acute respiratory distress syndrome randomized trials.Intensive care medicine · 2024Article
- Causes and attributable fraction of death from ARDS in inflammatory phenotypes of sepsis.Critical care (London, England) · 2024Article
- Attributable mortality of ARDS among critically ill patients with sepsis: a multicenter, retrospective cohort study.BMC pulmonary medicine · 2024Article
- Identifying a hyperinflammatory subphenotype of ARDS associated with worse outcomes: may ferritin help?Thorax · 2024Article
- What Are We Aiming for in Chronic Hypercapnic Respiratory Failure?Respiratory care · 2023Article
- Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity.Nature communications · 2023Article
Corrections and comments
- Commented on by
Authors and funding
14 authors at 12 institutions in 6 countries.
Funding
Abstract
backgroundEfficiency of randomised clinical trials of acute respiratory distress syndrome (ARDS) depends on the fraction of deaths attributable to ARDS (AF
methodsWe performed a matched case-control study using the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE cohort. Primary outcome was intensive care unit mortality. We used nearest neighbour propensity score matching without replacement to match ARDS to non-ARDS populations. We derived two separate AF
resultsEstimated AF
conclusionsOverall AF
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.